Vicks

Vicks is an American over-the-counter healthcare brand focused primarily on cold, cough, congestion and related respiratory symptoms. Its portfolio includes topical products, cough medicines, lozenges, nasal sprays, inhaled treatments and the NyQuil and DayQuil product families. In Latin American markets the brand is generally known as Vick, while in German-speaking markets outside Switzerland it is sold as Wick. The brand traces its roots to pharmacist Lunsford Richardson, who took over a drug business in North Carolina in 1890 and began marketing a line called Vick’s Family Remedies. Richardson’s business developed a topical salve for croup and pneumonia in 1891. The product was introduced commercially as Vick’s Magic Croup Salve in 1905 and was renamed VapoRub in 1912. VapoRub became the defining product of the brand, supported by extensive sampling and consumer promotion. During the 1918 influenza pandemic, sales rose sharply, helping establish Vicks as a household name in the United States. The company broadened its range over the following decades. It introduced cough drops in 1931, a portable mentholated inhaler in 1941, cough syrup in 1952, Sinex nasal spray in 1959 and NyQuil in 1966. DayQuil was subsequently developed as a daytime counterpart to NyQuil, and the wider Quil range became an important part of the brand’s cold-medicine business. Other Vicks offerings have included Formula 44 cough medicines, lozenges, nasal products and steam-based respiratory treatments. For much of its independent history, the brand was operated by the Richardson family’s company, first associated with Vick Chemical Company and later with Richardson-Vicks. Corporate restructuring in the early 1980s separated the prescription-drug activities of the broader Richardson-Merrell organization from the consumer over-the-counter business. Procter & Gamble acquired Richardson-Vicks in 1985, bringing Vicks into one of the world’s largest consumer-products portfolios. Vicks remains a Procter & Gamble brand, although selected businesses have changed ownership; in 2015, Procter & Gamble sold the United States VapoSteam liquid-inhalant business to Helen of Troy. Vicks is positioned as a mass-market, broadly distributed self-care brand. Its identity relies on recognizable mentholated sensory cues, strong household familiarity and products designed for symptom relief, particularly at night or during seasonal respiratory illness. Product availability, formulations and naming vary by country, and some products are marketed under related local brand names or through regional regulatory classifications.

Vicks developed from the North Carolina drug business taken over by pharmacist Lunsford Richardson in 1890. The business had been associated with his brother-in-law, Dr. John Vick, and Richardson used the Vick name for a growing range of family remedies. Early products included castor oil, liniment and vermifuge. The product that ultimately defined the brand began as a salve for croup and pneumonia, compounded in Greensboro in 1891. Richardson’s son, H. Smith Richardson, brought additional sales and marketing experience to the family business. The salve was introduced in 1905 as Vick’s Magic Croup Salve and was renamed VapoRub in 1912. The company promoted the product through broad consumer sampling and direct-mail activity. During the 1918 influenza pandemic, demand increased substantially, and VapoRub became widely associated with household treatment of cold and respiratory symptoms. Smith Richardson became company president after his father’s death in 1919. The company continued to add products as consumer medicine habits changed. Cough drops were introduced in 1931. In 1941, Vicks launched the VapoInhaler, a portable mentholated nasal inhaler that consumers commonly called the “Vick Stick.” Edward Mabry became president in 1948. Cough syrup followed in 1952, and the Sinex nasal-spray line was introduced in 1959. NyQuil entered the market in 1966, establishing a major nighttime cold-medicine platform that was later complemented by DayQuil and other products in the Quil family. The corporate entity operating the brand changed as the Richardson family’s business expanded and reorganized. Vick Chemical Company became associated with Richardson-Merrell, whose activities included both prescription and consumer medicines. In 1982, the business was divided into the prescription-focused Merrell Dow operation and the over-the-counter Richardson-Vicks operation. Procter & Gamble acquired Richardson-Vicks in 1985, making Vicks part of a global consumer-products company. Under Procter & Gamble, Vicks continued to operate as a recognizable consumer-health brand with products spanning topical rubs, cough medicines, lozenges, nasal treatments and inhaled respiratory products. Regional differences became an enduring feature of the brand. In Latin America it is commonly styled Vick, while German-speaking markets generally use the name Wick. Product formulas and regulatory status also vary by market. In March 2015, Procter & Gamble divested the United States VapoSteam liquid-inhalant business to Helen of Troy. This transaction affected a specific business line rather than the entire Vicks brand. The historical records of Richardson-Vicks and related Richardson family materials are held by the University of North Carolina at Chapel Hill. Vicks continues as an active Procter & Gamble over-the-counter healthcare brand.

• 2015

  VapoSteam United States business is sold

  [2]Procter & Gamble Sells Vicks VapoSteam U.S. Business to Helen of Troywsj.com

  Procter & Gamble sold the United States VapoSteam liquid-inhalant business to Helen of Troy.

• 1985

  Procter & Gamble acquires Richardson-Vicks

  [1]Vicksen.wikipedia.org

  Vicks became part of Procter & Gamble through its acquisition of Richardson-Vicks.

• 1982

  Richardson-Merrell separates prescription and consumer businesses

  [1]Vicksen.wikipedia.org

  The corporate structure was divided between Merrell Dow’s prescription-drug activities and Richardson-Vicks’ over-the-counter business.

• 1966

  NyQuil launches

  [1]Vicksen.wikipedia.org

  NyQuil established Vicks in the nighttime multi-symptom cold-medicine category.

• 1959

  Sinex nasal spray is introduced

  [1]Vicksen.wikipedia.org

  Vicks entered the nasal-spray segment with Sinex.

• 1952

  Vicks begins selling cough syrup

  [1]Vicksen.wikipedia.org

  Cough syrup expanded the brand’s presence in liquid cough remedies.

• 1941

  VapoInhaler is introduced

  [1]Vicksen.wikipedia.org

  Vicks introduced a portable mentholated nasal inhaler that became popularly known as the Vick Stick.

• 1931

  Vicks launches cough drops

  [1]Vicksen.wikipedia.org

  The company expanded beyond topical products into cough drops.

• 1918

  Influenza pandemic drives VapoRub demand

  [1]Vicksen.wikipedia.org

  VapoRub sales rose sharply during the 1918 influenza pandemic, accelerating the brand’s household recognition.

• 1912

  The salve is renamed VapoRub

  [1]Vicksen.wikipedia.org

  The flagship topical product adopted the VapoRub name, which became central to the Vicks identity.

Showing the 10 most recent.

A mass-market over-the-counter healthcare brand centered on familiar mentholated relief for coughs, colds, congestion and associated respiratory symptoms.

• Topical respiratory-relief product · 1905

  Vicks VapoRub

  VapoRub is the brand’s signature mentholated topical product. It originated as a salve for croup and pneumonia, was commercialized as Vick’s Magic Croup Salve in 1905 and received the VapoRub name in 1912. Its distinctive scent and topical format have made it the central heritage product in the Vicks portfolio.

• Nighttime cold medicine · 1966

  Vicks NyQuil

  NyQuil is a nighttime cold-medicine line introduced in 1966. It expanded Vicks beyond topical and single-symptom remedies into multi-symptom products associated with nighttime cold and cough care. Specific formulations and active ingredients differ across markets and product versions.

• Daytime cold medicine

  Vicks DayQuil

  DayQuil is the daytime counterpart to NyQuil within the Vicks Quil family. It is designed for daytime cold and cough symptom relief without being positioned as a nighttime product. Availability, dosage forms and ingredients vary by country.

• Cough medicine

  Vicks Formula 44

  Formula 44 is a Vicks cough-medicine line. It represents the brand’s expansion into liquid cough remedies and related cough-care formats beyond VapoRub and inhaled products.

• Nasal spray · 1959

  Vicks Sinex

  Sinex is Vicks’ nasal-spray line, introduced in 1959. It extends the brand’s respiratory-relief positioning into nasal congestion treatment, with product composition and regulatory classification varying between markets.

• Portable nasal inhaler · 1941

  Vicks VapoInhaler

  The VapoInhaler, introduced in 1941, is a portable mentholated inhaler intended to provide a concentrated vapor experience. Consumers commonly referred to the product as the Vick Stick, making it one of the brand’s historically recognizable inhaled treatments.

• Liquid inhalant

  VapoSteam

  VapoSteam is a liquid inhalant used with steam-based respiratory treatments. Procter & Gamble sold the United States VapoSteam business to Helen of Troy in 2015; ownership and availability therefore depend on the specific market and product.

• Cough drops and lozenges · 1931

  Vicks cough drops

  Vicks entered the cough-drop category in 1931. Cough drops and lozenges broaden the brand’s portfolio into portable throat and cough-care products and remain part of its historical product range.

• 1918VapoRub pandemic-era sampling and promotion

  United States

  Vicks distributed very large numbers of product samples and used direct-mail promotion to build awareness of VapoRub. The campaign activity coincided with the 1918 influenza pandemic and helped turn the product into a widely recognized household remedy.

  Outcome. VapoRub sales and brand recognition increased substantially.

  Source

• 2015

  Divest the United States VapoSteam businessM&A

  Background

  Procter & Gamble reshaped parts of its consumer-health portfolio while retaining the broader Vicks brand.

  Action taken

  The United States VapoSteam liquid-inhalant business was sold to Helen of Troy.

  Aftermath

  The transaction transferred a specific VapoSteam business rather than the complete Vicks portfolio.

  Source

• 1985

  Sell Richardson-Vicks to Procter & GambleM&A

  Background

  Following the separation of its consumer and prescription businesses, Richardson-Vicks was positioned as an acquisition target in consumer healthcare.

  Action taken

  Procter & Gamble acquired Richardson-Vicks and added the Vicks brand to its global consumer-products portfolio.

  Aftermath

  Vicks continued under Procter & Gamble ownership as an international over-the-counter healthcare brand.

  Source

• 1982

  Separate the consumer healthcare operationStrategy

  Background

  The broader Richardson-Merrell organization contained both prescription and over-the-counter healthcare activities.

  Action taken

  The business was reorganized into Merrell Dow for prescription drugs and Richardson-Vicks for over-the-counter products.

  Aftermath

  The Vicks business became a focused consumer-health operation before its acquisition by Procter & Gamble.

  Source

• 1966

  Launch NyQuilProduct launch

  Background

  Vicks had already established products in topical, inhaled and cough-care formats and expanded into a broader cold-medicine proposition.

  Action taken

  The company introduced NyQuil as a nighttime cold medicine.

  Aftermath

  NyQuil became a major Vicks product family and was later complemented by DayQuil and other Quil products.

  Source

• 1912

  Rename the flagship salve as VapoRubStrategy

  Background

  The company sought a more distinctive commercial identity for the salve first marketed as Vick’s Magic Croup Salve.

  Action taken

  The product was renamed VapoRub, creating the enduring flagship name associated with Vicks.

  Aftermath

  VapoRub became the brand’s principal heritage product and a foundation for later product expansion.

  Source

• 2015

  Procter & Gamble sells United States VapoSteam liquid-inhalant business[2]Procter & Gamble Sells Vicks VapoSteam U.S. Business to Helen of Troywsj.com

  M&A

  Procter & Gamble sold the United States VapoSteam liquid inhalant business to Helen of Troy while retaining the broader Vicks brand portfolio.

• 1985

  Procter & Gamble acquires Richardson-Vicks[1]Vicksen.wikipedia.org

  M&A

  Procter & Gamble purchased Richardson-Vicks, bringing the Vicks consumer healthcare brand into its portfolio.

1. 1Vicksen.wikipedia.org
2. 2Procter & Gamble Sells Vicks VapoSteam U.S. Business to Helen of Troywsj.com
3. 3Richardson-Vicks, Inc. Records, Southern Historical Collectionfinding-aids.lib.unc.edu